Pharmacologic basis for the treatment of cardiac arrhythmias.
D000328:Adult; D000367:Age Factors; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D001283:Atrioventricular Node / Q000187:drug effects; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D006207:Half-Life; D006327:Heart Block / Q000188:drug therapy; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007223:Infant; D007408:Intestinal Absorption; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D011342:Procainamide / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D011802:Quinidine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D012849:Sinoatrial Node / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide